S'abonner

A Nested Case–Control Study on Plasma Vitamin E and Risk of Cancer: Evidence of Effect Modification by Selenium - 25/04/19

Doi : 10.1016/j.jand.2018.11.017 
Jiancheng Wang, MD, Huiyuan Guo, PhD, Tengfei Lin, PhD, Yun Song, MD, Hao Zhang, PhD, Binyan Wang, PhD, Yan Zhang, MD, Jianping Li, MD, Yong Huo, MD, Xiaobin Wang, MD, ScD, Xianhui Qin, MD, PhD , Xiping Xu, MD, PhD

Address correspondence to: Xianhui Qin, MD, PhD, Renal Division, Nanfang Hospital, Southern Medical University, No. 1023, South Shatai Road, Baiyun District, Guangzhou, Guangdong 510515, China.Renal DivisionNanfang HospitalSouthern Medical UniversityNo. 1023South Shatai RoadBaiyun DistrictGuangzhouGuangdong510515China

Abstract

Background

Evidence from epidemiologic studies has been inconsistent regarding the role of vitamin E in cancer incidence risk.

Objective

The aim of this study was to evaluate the prospective association between baseline plasma vitamin E levels and subsequent cancer risk in Chinese adults with hypertension, and to identify effect modifiers.

Design

A nested, case–control study was conducted from 20,702 hypertensive participants in the China Stroke Primary Prevention Trial, a randomized, double-blind, controlled trial, conducted from May 2008 to August 2013.

Participants

The current study included 229 new cancer cases and 229 controls matched for age (±1 year), sex, treatment group, and study site.

Main outcome measures

Plasma vitamin E was measured by liquid chromatography with tandem quadrupole mass spectrometers and plasma selenium was measured by inductively coupled plasma mass spectrometry using Thermo Fisher iCAP Q ICP-MS.

Statistical analyses

Odds ratios (OR) of cancer in relation to plasma concentrations of vitamin E were calculated using conditional logistic regression models.

Results

Median follow-up duration was 4.5 years. Overall, vitamin E was not associated with subsequent risk of total cancer (per 1-mg/L [2.3 μmol/L] increase: OR 1.01, 95% CI 0.93 to 1.09) and non-gastrointestinal cancer (OR 1.10, 95% CI 0.98 to 1.24). However, there was a significant, inverse association between vitamin E and gastrointestinal cancer (OR 0.86, 95% CI 0.75 to 0.99), particularly esophageal cancer (OR 0.67, 95% CI 0.48 to 0.95). Moreover, high vitamin E decreased the risk of total cancer (OR 0.91, 95% CI 0.84 to 0.99) and gastrointestinal cancer (OR 0.83, 95% CI 0.73 to 0.95) among patients with high selenium levels (median≥83.7 μg/L [1.1 μmol/L]), and increased the risk of total cancer (OR 1.13, 95% CI 1.00 to 1.26) and non-gastrointestinal cancer (OR 1.25, 95% CI 1.03 to 1.50) among those with low selenium levels (<83.7 μg/L [1.1 μmol/L]).

Conclusions

This study suggests that higher levels of plasma vitamin E are associated with reduced risk of gastrointestinal cancer. High vitamin E decreased the risk of total cancer among patients with high selenium levels, but increased the risk of total cancer among those with low selenium levels.

Le texte complet de cet article est disponible en PDF.

Keywords : Vitamin E, Selenium, Cancer incidence, Antioxidant, Hypertension


Plan


 STATEMENT OF POTENTIAL CONFLICT OF INTEREST X. Xu reports grants from the Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing; the Science and Technology Planning Project of Guangzhou, China; the Science, Technology and Innovation Committee of Shenzhen. X. Qin reports grants from the Projects of the National Natural Science Foundation; the President Foundation of Nanfang Hospital, Southern Medical University; and the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University. Y. Huo reports grants from National Key Research and Development Program. No potential conflict of interest was reported by the remaining authors.
 FUNDING/SUPPORT This work was supported by the National Key Research and Development Program (2016YFC0903101, 2016YFC0904900, 2016YFE0205400), the Projects of the National Natural Science Foundation of China (81473052 and 81402735); the Science and Technology Planning Project of Guangzhou, China (201707020010); the Science, Technology and Innovation Committee of Shenzhen (KQCX20120816105958775, JSGG20160229173428526, JSGG20170412155639040, GJHS20170314114526143, KC2014JSCX0071A); the President Foundation of Nanfang Hospital, Southern Medical University (2017C007), the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University (2017J009).
 The CSPPT was registered with ClinicalTrials.gov (ID NCT00794885).
 AUTHOR CONTRIBUTIONS X. Xu and X. Qin contributed to conceived the study and funding acquisition. J. Wang and H. Guo contributed to the data collection, statistical analyses, and original drafting of the manuscript. All authors reviewed and commented on subsequent drafts of the manuscript.


© 2019  Academy of Nutrition and Dietetics. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 119 - N° 5

P. 769-781 - mai 2019 Retour au numéro
Article précédent Article précédent
  • Diet Quality Is an Indicator of Disease Risk Factors in Hispanic College Freshmen
  • Matthew J. Landry, Fiona M. Asigbee, Sarvenaz Vandyousefi, Erfan Khazaee, Reem Ghaddar, Jessica B. Boisseau, Benjamin T. House, Jaimie N. Davis
| Article suivant Article suivant
  • Theoretical Reductions in Discretionary Choices Intake via Moderation, Substitution, and Reformulation Dietary Strategies Show Improvements in Nutritional Profile: A Simulation Study in Australian 2- to 18-Year-Olds
  • Brittany J. Johnson, Jessica A. Grieger, Thomas P. Wycherley, Rebecca K. Golley

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.